1696 — Sisram Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.46bn
- HK$1.39bn
- $359.29m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 24.8 | 16.7 | 41.7 | 44.2 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.52 | 3.45 | 7.85 | 15 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14 | -4.83 | -29.4 | -49.6 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 21 | 25.7 | 32.4 | 22 | — |
Capital Expenditures | -3.17 | -9.27 | -2.96 | -5.07 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 56.9 | -24.2 | -43.8 | -47 | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 53.7 | -33.5 | -46.8 | -52.1 | — |
Financing Cash Flow Items | 0.267 | -0.75 | -12.5 | -2.46 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -9.36 | -12.2 | 55.8 | -17.8 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 65.9 | -16.4 | 41.5 | -50.1 | — |